Design and initiation of a study to assess the direct and indirect effects of influenza vaccine given to children in rural India.

University of Alabama Birmingham, Birmingham, AL, USA.
Vaccine (Impact Factor: 3.49). 06/2012; 30(35):5235-9. DOI: 10.1016/j.vaccine.2012.06.002
Source: PubMed

ABSTRACT The burden of disease due to influenza is not well characterized for children in developing countries and the effectiveness of available influenza vaccines in lower resource settings has not been established. We initiated a prospective, longitudinal, phase IV, household-randomized, controlled, observer-blinded three year study (2009-2011) in a rural community of India to measure the total and indirect household protective effects of immunizing children ages 6 months through 10 years with seasonal inactivated trivalent influenza vaccine (TIV) or a control vaccine (n=3697). Active weekly surveillance was conducted year round with home visits for identification of febrile acute respiratory illness (FARI) conducted for all vaccine recipients and household members (n=18,220). Nasal and throat swabs were collected from each FARI episode for influenza detection by real-time reverse transcription polymerase chain reaction. The primary outcome was reduction in laboratory confirmed influenza infections in the influenza vaccine versus control vaccine group, with secondary outcome assessing indirect effects among the entire study population. This report describes the study site, cluster study design, choice of study and control vaccines, and the initial enrollment in the study.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Background & objectives: Most studies on the clinical presentation with influenza viruses have been conducted in outpatient or inpatient medical facilities with only a few studies in community settings. Clinical differences between influenza A (H1N1) pdm 09 and influenza B virus infections have importance for community-based public health surveillance. An active community surveillance at the time of emergence of pandemic influenza provided us with an opportunity to compare the clinical features among patients infected with influenza A (H1N1) pdm09 virus and those with influenza B virus co-circulating in an active community-based weekly surveillance in three villages in Faridabad, Haryana, north India. Methods: Active surveillance for febrile acute respiratory infection (FARI) was carried out in a rural community (n=16,182) in the context of an inactivated trivalent influenza vaccine trial (among children <11 yr). Individuals with FARI were assessed clinically by nurses and respiratory samples collected and tested for influenza viruses by real time RT-PCR from November 2009 to August 2010. Clinical symptoms of patients with influenza A (H1N1) pdm 09 and influenza B infection were compared. Results: Of the 4796 samples tested, 822 (17%) were positive for influenza virus. Of these, 443 (54%) were influenza A (H1N1) pdm09, 373 (45%) were influenza B and six were other subtypes/mixed infections. The mean age was lower for patients with influenza B (16.4 yr) than influenza A (H1N1) pdm09 infection (18.7 yr; P=0.04). Among children aged 5-18 yr, chills/rigours (OR 4.0; CI 2.2, 7.4), sore throat (OR 6.8; CI 2.3, 27.3) and headache (OR2.0; CI 1.3, 3.3) were more common in influenza A (H1N1) pdm09 infection than in influenza B cases. Chills/rigours (OR 2.4; CI 1.4, 4.0) and headache (OR 1.7; CI 1.0, 2.7) were associated with influenza A (H1N1) pdm09 infection in those >18 yr. No significant differences were seen in children <5 yr. Conclusion: Our findings show that the differences in the clinical presentation of influenza A(H1N1)pdm09 and influenza B infections are not likely to be of clinical or public health significance.
    The Indian Journal of Medical Research 12/2013; 138(6):962-8. · 1.66 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Though respiratory viruses are thought to cause substantial morbidity globally in children aged <5 years, the burden of severe respiratory virus infections in children is unknown in India where 20% of the world's children live. During August 2009-July 2011, prospective population-based surveillance was conducted for hospitalizations of children aged <5 years in a rural community in Haryana State. Clinical data and respiratory specimens were collected. Swabs were tested by RT-PCR for influenza and parainfluenza viruses, respiratory syncytial virus (RSV), human metapneumovirus, coronaviruses, and adenovirus. Average annual hospitalization incidence was calculated using census data and adjusted for hospitalizations reported on a community healthcare utilization survey to occur at non-study hospitals. Of 245 hospitalized children, respiratory viruses were detected among 98 (40%), of whom 92 (94%) had fever or respiratory symptoms. RSV (34.6/10,000, 95% CI 26.6-44.7) accounted for the highest virus-associated hospitalization incidences and 20% of hospitalizations. There were 11.8/10,000 influenza-associated hospitalizations (7% of hospitalizations). RSV and influenza detection peaked in winter (November-February) and rainy seasons (July), respectively. Respiratory viruses were associated with a substantial proportion of hospitalizations among young children in a rural Indian community. Public health research and prevention in India should consider targeting RSV and influenza in young children.
    The Journal of infection 11/2013; 68(3). · 4.13 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: School-age children suffer high rates of influenza virus infections and associated illnesses each year, and are a major source of transmission in the community. However, information on the cumulative incidence of infection in specific epidemics is scarce, and there are limited studies with sufficient follow-up to identify the strength and duration of protection against re-infection. We randomly allocated children 5-17y of age to receive trivalent inactivated influenza vaccine (TIV) or placebo from September 2009 through January 2010, and then conducted follow up for 3 years including regular collection of sera, symptom diaries, and collection of nose and throat swabs during illness episodes in subjects or their household members. Of 796 children initially randomized, 484 continued to participate for all three years. In unvaccinated children, cumulative incidence of infection was estimated to be 59% in the first wave of H1N1pdm09 in 2009-10, and 7%, 14%, 20% and 31% in subsequent epidemics of H3N2 (2010), H1N1pdm09 (2011), B (2012) and H3N2 (2012), respectively. Infection with H1N1pdm09 in 2009-10 and H3N2 in 2010 was associated with protection against infection with subsequent epidemics of the same subtype in 2011 and 2012 respectively, but we found no evidence of heterotypic or heterosubtypic protection against infection. We identified substantial incidence of influenza virus infections in children in Hong Kong in 5 major epidemics over a three year period, and evidence of homosubtypic but not heterosubtypic protection following infection.
    Clinical Infectious Diseases 05/2014; · 9.42 Impact Factor


Available from
May 21, 2014